BEGIN:VCALENDAR VERSION:2.0 METHOD:PUBLISH PRODID:-//Telerik Inc.//Sitefinity CMS 15.4//EN BEGIN:VTIMEZONE TZID:UTC BEGIN:STANDARD DTSTART;VALUE=DATE:20250101 TZNAME:UTC TZOFFSETFROM:+0000 TZOFFSETTO:+0000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DESCRIPTION:\nThe world isn&rsquo\;t flat\, so why is your prior?\n \;\ nThe pharmaceutical industry is increasingly turning to Bayesian methods i n early phase trials in an attempt to improve efficiency and enhance decis ion making. One reason for this growing interest is the ability of Bayesia n methods to leverage relevant external information\, be this historical d ata or expert opinion. This 1-day scientific meeting provides an opportuni ty to learn about some of the main techniques for incorporating historical data into study analyses using different discounting methods\, and for el iciting expert prior information in situations where no or limited histori cal data are available. \; \nFurther updates and exact timings to the programme will be forthcoming. Confirmed Speakers: \nNicky Best (GSK): Pri or elicitation in practice: early experiences with eliciting expert belief s to enhance decision making in drug development Nelson Kinnersley (Roche) : Practical Considerations when Eliciting Expert Beliefs for Clinical Tria l Design \;\nNelson will share experiences gained from conducting elic itation sessions in the clinical trial domain. Aspects of preparation\, tr aining\, conducting and documenting the outcomes will be described. Tony O &rsquo\;Hagan (Sheffield University): Where do we need expert judgment in drug development? ... Everywhere. \nKate Ren (Sheffield University): Elici tation in clinical trial planning: time-to-event data Beat Neuenschwander (Novartis): \; Using Co-Data in Early Phase Clinical Trials: Practical and Methodological Aspects Registration on or before 23rd July\nPSI Membe rs: \;£\;100.00 (plus VAT)\nNon-Members*: \;£\;140.00 (p lus VAT)\nAcademics*: \;£\;40.00 (plus VAT) Registration after 23 rd July\nPSI Members: \;£\;140.00 (plus VAT)\nNon-Members*: \ ;£\;200.00 (plus VAT)\nAcademics*: \;£\;70.00 (plus VAT) * P rice includes 1 year PSI affiliate membership Early registration is encour aged as places are limited. Contact: \;\nPSI Secretariat psi@mci-group .com\nTel: +44 (0) \; 845 1800 349\nFax: +44 (0) 1730 715291 \;&nb sp\; \;\nDurford Mill\, Petersfield\, Hampshire GU31 5AZ YOU CAN NOW R EGISTER \;\nAND PAY ONLINE AT \;www.psiweb.org MEETING ABSTRACTS W ILL BE POSTED ON \;www.psiweb.org Attendance at the course counts as 7 .5 hours towards any CPD requirements Many thanks to GSK \;\nfor hosti ng the September event. \; If you would like to host a PSI one day mee ting for a topic of particular \;\ninterest to you please contact:&nbs p\; nickm@amgen.com\n(Scientific Chair) PSI DTEND:20140903T173000Z DTSTAMP:20260905T082051Z DTSTART:20140903T090000Z LOCATION:Hertfordshire\, SG1 2NY\,England\,Stevenage\,Gunnels Wood Road SEQUENCE:0 SUMMARY:Prior Elicitation UID:RFCALITEM639241932517399338 X-ALT-DESC;FMTTYPE=text/html:

\nThe world isn&rsquo\;t flat\, so why is your prior?
\n \;
\nThe pharmaceutical indus try is increasingly turning to Bayesian methods in early phase trials in a n attempt to improve efficiency and enhance decision making. One reason fo r this growing interest is the ability of Bayesian methods to leverage rel evant external information\, be this historical data or expert opinion. Th is 1-day scientific meeting provides an opportunity to learn about some of the main techniques for incorporating historical data into study analyses using different discounting methods\, and for eliciting expert prior info rmation in situations where no or limited historical data are available.&n bsp\;

\nFurther updates and exact timings to the programme wil l be forthcoming.

Confirmed Speakers:

\nNicky Best (GSK): Prior elicitation in practice: early experiences with eliciting expert beliefs to enhance decision making in drug development

Nelson Kinnersley (Roche): Practical Considerations when Eliciting Ex pert Beliefs for Clinical Trial Design \;
\nNelson will share exp eriences gained from conducting elicitation sessions in the clinical trial domain. Aspects of preparation\, training\, conducting and documenting th e outcomes will be described.

Tony O&rsquo\;Hagan (Sheffield Univer sity): Where do we need expert judgment in drug development? ... Everywher e.

\nKate Ren (Sheffield University): Elicitation in clinical trial planning: time-to-event data

Beat Neuenschwander (Novartis):& nbsp\; Using Co-Data in Early Phase Clinical Trials: Practical and Methodo logical Aspects

Registration on or before 23rd July
\nPSI Members: \;£\;100.00 (plus VAT)
\nNon-Members*:  \;£\;140.00 (plus VAT)
\nAcademics*: \;£\;40.00 (p lus VAT)

Registration after 23rd July
\nPSI M embers: \;£\;140.00 (plus VAT)
\nNon-Members*: \;£\ ;200.00 (plus VAT)
\nAcademics*: \;£\;70.00 (plus VAT)

< p>* Price includes 1 year PSI affiliate membership

Early re gistration is encouraged as places are limited.

Contact:&n bsp\;
\nPSI Secretariat
psi@ mci-group.com
\nTel: +44 (0) \; 845 1800 349
\nFax: +44 (0) 1730 715291 \; \; \;
\nDurford Mill\, Petersfield\, H ampshire GU31 5AZ

YOU CAN NOW REGISTER \;
\nAND PAY ONLINE AT \;www.psiweb.org

MEETI NG ABSTRACTS WILL BE POSTED ON \;www. psiweb.org

Attendance at the course counts as 7.5 hours towards any CPD requirements

Many thanks to GSK \;
\nfor hosting the September event. \;

If you would like to host a PSI one day meeting for a topic of particular \;
\ninterest to you please co ntact: \;
nickm@amgen.com\n(Scientific Chair) PSI

END:VEVENT END:VCALENDAR